These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10868304)

  • 21. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
    Quiroz J; Ting N; Wei GC; Burdick RK
    Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral.
    Kees F; Mair G; Dittmar M; Bucher M
    Transplant Proc; 2004 Dec; 36(10):3234-8. PubMed ID: 15686736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bioequivalence studies of pharmaceutical preparations].
    Vetchý D; Frýbortová K; Rabisková M; Danecková H
    Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of selective analytical techniques in bioequivalence testing.
    Lapka R; Ulc I; Kakác B; Rejholec V
    Pharmazie; 1988 Jan; 43(1):50-1. PubMed ID: 3375307
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bioequivalence of enteric coated tablet of Zhengqing Fengtongning].
    Zhang SH; Zhou YD; He HX
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):683-5. PubMed ID: 18590201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statistical evaluation of physiological variability of rifampicin in fixed dose combinations.
    Panchagnula R; Parmar J; Kaur K; Singh I; Bade SR; Ashokraj Y
    Int J Pharm; 2006 Apr; 313(1-2):5-13. PubMed ID: 16517107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability/bioequivalence: study design and statistical issues.
    Metzler CM
    J Clin Pharmacol; 1989 Apr; 29(4):289-92. PubMed ID: 2656773
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biorhythms of bioavailability ("chronogalenics")].
    Hüttenrauch R
    Pharmazie; 1980; 35(11):709-11. PubMed ID: 7465616
    [No Abstract]   [Full Text] [Related]  

  • 29. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contributions to medicine from bioavailability studies.
    Sharoky M
    Md Med J; 1987 Jul; 36(7):585-8. PubMed ID: 2888000
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bioavailability of medications].
    Farré M; Roset PN; Mas M; Mas A
    Med Clin (Barc); 1998 Apr; 110(14):558. PubMed ID: 9646275
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study.
    Liao JJ
    Stat Med; 2005 Mar; 24(6):883-91. PubMed ID: 15558699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "One-size-fits-all" in bioavailability and bioequivalence testing?
    Blume HH
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):419-20. PubMed ID: 19640347
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioavailability versus bioequivalence: the cyclosporine model.
    Masri MA
    Exp Clin Transplant; 2003 Dec; 1(2):119-24. PubMed ID: 15859918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open questions on bioequivalence: the case of multiple peak phenomenon.
    Marzo A; Reiner V
    J Pharm Pharmacol; 2004 Feb; 56(2):281-2. PubMed ID: 15005889
    [No Abstract]   [Full Text] [Related]  

  • 36. The bioavailability of drugs.
    Mishra B; Bhattacharya SK
    Natl Med J India; 1993; 6(2):85-8. PubMed ID: 8477218
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical microdialysis in skin and soft tissues: an update.
    Schmidt S; Banks R; Kumar V; Rand KH; Derendorf H
    J Clin Pharmacol; 2008 Mar; 48(3):351-64. PubMed ID: 18285620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.